Concepedia

Marialuisa Moccia

MM

6

Publications

124

Citations

6

H-Index

2014

Active since

Affiliations

University of Naples Federico II(Current)

Institute for Experimental Endocrinology and Oncology

University of Arkansas for Medical Sciences

Marialuisa Moccia is an author at University of Naples Federico II specializing in drug discovery, medicine, and drug development.

Top concepts

Publications per year

2014–2022

6

Publications

6

Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology

Marialuisa Moccia, Brendan Frett, Lingtian Zhang et al. · Journal of Medicinal Chemistry · 2020 · 26 citations · Full text

Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation

Wei Yan, Lingtian Zhang, Fengping Lv et al. · European Journal of Medicinal Chemistry · 2021 · 25 citations · Full text

, , +11

Identification of two novel RET kinase inhibitors through MCR-based drug discovery: Design, synthesis and evaluation

Brendan Frett, Marialuisa Moccia, Francesca Carlomagno et al. · European Journal of Medicinal Chemistry · 2014 · 21 citations · Full text

, , +10

Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase

Marialuisa Moccia, Qingsong Liu, Teresa Guida et al. · PLoS ONE · 2015 · 20 citations · Full text

, , +15

Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases

Marialuisa Moccia, Donglin Yang, Naga Rajiv Lakkaniga et al. · Scientific Reports · 2021 · 16 citations · Full text

Rows per page

1–5 of 6